SUTRO BIOPHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sutro Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • Sutro Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $5.92M, a 4.95% decline year-over-year.
  • Sutro Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $24.7M, a 0.89% decline year-over-year.
  • Sutro Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $24.7M, a 0.89% decline from 2023.
  • Sutro Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $24.9M, a 5.31% decline from 2022.
  • Sutro Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.3M, a 13.2% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $24.7M -$221K -0.89% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $24.9M -$1.4M -5.31% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $26.3M +$3.06M +13.2% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 $23.2M +$11.3M +95% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-25
2020 $11.9M +$1.61M +15.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $10.3M +$7.44M +259% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $2.87M +$1.48M +106% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $1.39M +$423K +43.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $968K Jan 1, 2016 Dec 31, 2016 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.